Jiamusi Cancer Hospital

Jiamusi, Heilongjiang 154007

2 studies enrolling now · 5 studies all time

What they study most

Advanced Solid Tumors, Extensive Stage Small-cell Lung Cancer, Extensive-Stage Small-Cell Lung Cancer, Limited-Stage Small Cell Lung Cancer, Small-Cell Lung Cancer, Small-cell Lung Cancer, Squamous Non Small Cell Lung Cancer

Studies at this site

• A Study of BG-C477 in Participants With Advanced Solid Tumors — Recruiting now
• A Study Comparing Tarlatamab, Durvalumab, Carboplatin, and Etoposide Versus Durvalumab, Carboplatin, and Etoposide in First-line Extensive Stage Small-Cell Lung Cancer (ES-SCLC) — Recruiting now
• A Study to Evaluate the Efficacy and Safety of Serplulimab in Combination With Chemotherapy and Concurrent Radiotherapy in Patients With Limited-Stage Small Cell Lung Cancer — Running, not enrolling
• Study Comparing Tarlatamab and Durvalumab Versus Durvalumab Alone in First-Line Extensive-Stage Small-Cell Lung Cancer (ES-SCLC) Following Platinum, Etoposide and Durvalumab — Running, not enrolling
• A Randomized, Double-blind, Placebo Controlled Phase III Study to Investigate Efficacy and Safety of First-Line Treatment With HLX10 + Chemotherapy (Carboplatin-Nanoparticle Albumin Bound (Nab) Paclitaxel) in Patients With Stage IIIB/IIIC or IV NSCLC — Status unconfirmed